This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
The CHMP’s recommendation will now be reviewed by the European Commission, which has the authority to approve medicines for use in the 27 EU member states, as well as Norway,
taxpayers.". As part of the agreement, UK scientists will gain access to the world’s largest research collaboration programme, Horizon Europe, and cooperation will be opened up with the EU, Norway,
applicable to all 27 EU member states plus Iceland, Norway and Liechtenstein.
Norway and Liechtenstein.
The authorisation is the first paediatric approval for Biktarvy in the EU and applies to all 27 member states, as well as Norway, Iceland and Liechtenstein.
The approval, which is applicable to all 27 member states of the EU, plus Iceland and Norway, follows a positive opinion granted in September by the Committee for Medicinal Products for
More from news
Approximately 1 fully matching, plus 147 partially matching documents found.
Most biosimilar products are introduced into markets through tenders. We have seen discounts of 85% in Norway and 45% in France, following local negotiations.
The Coalition for Epidemic Preparedness Innovations (CEPI), an Oslo, Norway-based nonprofit, is helping to coordinate the development of a COVID-19 vaccine and is leading the efforts to finance the
Notably the biosimilar Renflexis (infliximab-abda) achieved a 70-80% price reduction to its reference product in both Norway and Denmark.
As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
Was formerly general manager of Abbott in Norway. AbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business. ... Regan was formerly general manager for Abbott in Norway and will now oversee
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
No results were found
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....